GEN Edge - Latest

Latest

Blood Disorders

Can Graphite Bio Realize the Promise of CRISPR Gene Editing to Develop One-time Cures?

Nanotechnology

Clene Energy: Nanocrystal Developer Pursues Remyelination vs. MS, ALS

GEN 40

StockWatch: After Bluebird’s Second Approval, Investors Are Looking for More

Artificial Intelligence

SpIntellx Powers Precision Pathology with Spatial AI

Drug Discovery

What A Trip: Delix Therapeutics is Treating Mental Health at Scale with Psychoplastogens

Vaccine Development

StockWatch: BioNTech Sees No Bounce from Promising Cancer Vaccine Data

Illumina

StockWatch: Illumina Bounces Back After FTC Win, EU Loss

Animal Models

The Netflix of Digital Biology? Recursion Is Reimagining Drug Discovery

Drug Discovery

On the Map: Cartography Charts a Course for Precision Cancer Treatments

Coronavirus

StockWatch: Novavax Hits 52-Week Low as Rivals Win FDA Omicron Booster OKs

Protein Therapeutics

Engineerable Biology: Generate Builds Pipeline, Expands Modalities

GEN Edge

Atalanta Therapeutics’ Branched RNAi Hunts Down Neurodegenerative Diseases

Neurological Disorders

StockWatch: Minerva’s a Home Run with N.Y. Mets Owner

Antibodies

The Logical Song: Biolojic Design Reimagines Antibodies into “Smart” Therapeutics

DNA

Molecular Assemblies Is Enzymatically Synthesizing the Next Generation of DNA Products

Cell Therapy

Pipeline Progress: Sangamo CEO Discusses Cell, Gene Therapies

Drug Delivery

Senda Acquires $123 Million for Clinical-Stage Transformation

GEN Edge

Cemvita Is Fighting Climate Change with Synthetic Biology

Coronavirus

StockWatch: Novavax Sinks with Revenue Forecast, Vaccine Demand

Financing

“Bullish” Biopharma M&A Market Predicted for Closing Months of 2022

Artificial Intelligence

Apriori Bio’s AI Platform Provides Variant-Proof Protection from Viral Threats

RNAi

StockWatch: Alnylam Basks in the Glow of Heart Drug’s Phase III Success

Cancer

ElevateBio and Boston Children’s Reveal New Company for Manufacturing Allogenic Immune Therapies

RNA

Mountain Climbing: CAMP4 Aims to Scale the Heights of Disease

Artificial Intelligence

AI Has the Potential to Improve Efficiency of Clinical Trials

CRISPR-Cas9

Let There Be Xenotransplants: eGenesis Trudges Towards the Clinic

Women's Health

StockWatch: ObsEva Shares Crumble on Layoff Plans after FDA ‘Review Issues’

OMICs

Signal Strength: Pleno’s Multiomics Tools Apply Telecom Techniques

GEN Edge

Replay Launches with $55 Million Seed to Transform Genomic Medicine with Interlinking Technology Platforms

Coronavirus

StockWatch: Valneva, Novavax Stocks Swing with COVID-19 Developments